Course overview:

Bone Turnover Markers (BTM) have long been used as diagnostic tests for metabolic bone diseases. In the past 20 years, markers that are more specific to bone have been introduced and have been found to be useful in osteoporosis, particularly for monitoring treatment. This course aims to provide a background to the clinical use of bone turnover markers.

Target audience:

This day-long course is open to clinicians (e.g. endocrinology, rheumatology, care of the elderly and clinical chemistry), laboratory scientists and nurses involved in the clinical management of patients at risk of osteoporotic fractures.

Objectives:

At the end of the course, participants should:

• understand the process of bone remodelling and how this can be studied using BTM
• appreciate the methods used for measuring BTM and their sources of variability
• be able to identify the role of BTM in the diagnosis and monitoring of bone diseases in a number of clinical settings including; osteoporosis, chronic kidney disease, Paget’s disease, osteomalacia,GIOP and PHPT.
• be familiar with best practice in the clinical use of BTM

Registration:

You can register to the ECTS-Mellanby Training Course here

Programme:

10:35-11:05    SOURCES OF VARIABILITY IN BTM, Jennifer Walsh (Sheffield, UK)

11:05-11:30    COFFEE BREAK

11:30-12:00    USE OF BTM IN OSTEOPOROSIS: SHARED CARE PROTOCOLS IN PRIMARY CARE, Richard Eastell (Sheffield, UK)

12:00-13:00    INTERACTIVE WORKSHOPS

GROUP A: PROTOCOLS AND CASE EXAMPLES FOR THE USE OF BTM IN OSTEOPOROSIS PRACTICE, Jennie Walsh  (Sheffield, UK) and Eugene McCloskey

GROUP B: USING BTM FOR OSTEOPOROSIS TREATMENT: RESEARCH APPLICATION, Richard Eastell (Sheffield, UK) and Nuria Guanyabens (Barcelona)

13:00-13:40    LUNCH

13:40-14:30    METABOLIC BONE DISEASES IN ADULTS (Pagets, Osteomalacia, GIOP & PHPT), Eugene McCloskey (Sheffield, UK)

14:30-15:00    METABOLIC BONE DISEASE OF CHRONIC KIDNEY DISORDER, Barbara Obermeier-Pietsch (Graz, Austria)

15:00-15:30    WHEN AND HOW TO USE BONE HISTOMORPHOMETRY, Erik Eriksen (Oslo, Norway)

15:30-15:50    COFFEE BREAK

15:50-16:50    INTERACTIVE WORKSHOPS

GROUP A: PROTOCOLS FOR THE USE OF BTM IN OSTEOPOROSIS PRACTICE, Jennie Walsh (Sheffield, UK) and Erik Eriksen (Oslo, Norway)

GROUP B: USING BTM IN METABOLIC BONE DISEASE, Eugene McCloskey (Sheffield, UK) and Nuria Guanyabens (Barcelona)

17:10-17:30    EXPERT PANEL: QUESTIONS AND ANSWERS, All speakers

17:30        CLOSE OF DAY